A pharmacokinetic model of intravitreal delivery of ganciclovir

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 47, Issue 2, 1999, Pages 99-104

  Tojo, Kakuji ^a   Nakagawa, Katsunori ^a   Morita, Yasushi ^a   Ohtori, Akira ^a  

^a KYUSHU INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Biodegradable polymer; Ganciclovir; Intravitreal delivery; Ocular pharmacokinetics; Vitreous body

Indexed keywords

GANCICLOVIR; POLYMER;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG ELIMINATION; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; MATHEMATICAL MODEL; MODEL; PHARMACOKINETICS; VITREOUS BODY;

ANIMALS; ANTIVIRAL AGENTS; GANCICLOVIR; HUMANS; MODELS, BIOLOGICAL; RABBITS; VITREOUS BODY;

EID: 0032967156     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(98)00073-3     Document Type: Article

References (18)

1. A. Merkli, C. Tabatabay, R. Gurny, Use of insoluble biodegradable polymers in ophthalmic systems for the sustained release of drugs, Eur. J. Pharm. Biopharm. 41 (1995) 271-283.
2. N. Worakal, J.R. Robinson, Ocular pharmacokinetics/pharmacodynamics, Eur. J. Pharm. Biopharm. 44 (1997) 71-81.
3. H.L. Cantrill, K. Henry, N.H. Melroe, W.H. Knobloch, R.C. Ramsay, N.H. Balfour, Treatment of cytomegalovirus retinitis with intravitreal ganciclovir, Ophthalmology 96 (1989) 367-374.
4. F.M. Ussery, S.R. Gibson, R.H. Conklin et al., Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis, Ophthalmology 95 (1988) 640-648.
5. I. Cochereau-Massin, P. Lehoang, M. Lautier-Frau et al., Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome, Ophthalmology 98 (1991) 1348-1355.
6. J. Ben-Nun, D.A. Joyce, R.L. Cooper, S.J. Cringle, I.J. Constable, Pharmacokinetics of intravitreal injection, Invest. Ophthal. Vis. Sci. 30 (1989) 1055-1061.
7. A. Ohtori, K. Tojo, In vivo/in vitro correlation of intravitreal delivery of drugs with the help to computer simulation, Biol. Pharm. Bull. 17 (1994) 283-290.
8. K. Uno, A. Ohtori, K. Tojo, Drug transport in the vitreous body of rabbits in vitro, J. Eye (Atarashii Ganka) 11 (1994) 607-609.
9. N. Kunou, Y. Ogura, M. Hashizoe, Y. Honda, S.H. Hyon, Y. Ikada, Controlled intraocular delivery of ganciclovir with use of biodegradable scleral implant in rabbits, J. Cont. Rel. 37 (1995) 143-150.
10. T.J. Smith, P. Pearson, D.L. Blandford et al., Intravitreal sustained-release ganciclovir, Arch. Ophthalmol. 110 (1992) 255-258.
11. G.E. Sanborn, R. Anand, R.E. Torti et al., Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis, Arch. Ophthalmol. 110 (1992) 188-195.
12. V.E. Kinsey, Ion movement in the eye, Circulation 21 (1960) 968-987.
13. P.J.D. Mayes, Method of lines, Biotech. Prog. 1 (1985) 269-273.
14. K. Tojo, L.T. Fan, Membrane moderated controlled release, Math. Biosci. 57 (1981) 279-300.
15. L.M. Sanders, G.I. McRae, K.M. Vitale, B.A. Kell, Controlled delivery of an LHRH analogue from biodegradable injectable microspheres, J. Cont. Rel. 2 (1985) 187-195.
16. K. Tojo, D.S. Desai, J. Eye (Atarashii Ganka) 8 (1991) 945-948.
17. K. Nakagawa, Movement of drugs in the eye, MS Thesis, Kyushu Institute of Technology, 1995.
18. M. Hashizoe, Y. Ogura, T. Kunou, Y. Honda, Y. Ikada, Biodegradable polymer device for sustained intravitreal release of ganciclovir in rabbits, Curr. Eye Res. 16 (1977) 633-639.